Skip to content

S. Woods

6 papers in the library · 5 citations · publishing 2015-2026

Papers

Sort Most recent Most cited

Cannabis and tobacco co-use predicts psychosis in clinical high risk cohorts

Nature Mental Health May 1, 2026 Daniel Bello, Sophia H. Blyth, Rachel A Rabin et al.

Cannabis and tobacco use are highly prevalent among people with psychosis and are associated with medical comorbidities and poor prognosis. Concurrent use of cannabis and tobacco (‘co-use’) is rising in the general population, but has not been studied in psychosis. Given the devastating consequences of cannabis and tobacco use, it is critical to understand how their co-use affects psychiatric...

Cannabis and Tobacco Co-Use Is Associated With Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis.

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging April 1, 2026 Daniel Bello, J. Connolly, Jean Addington et al.

BACKGROUND Cannabis use is highly prevalent among people with psychotic disorders. While there is some indication that cannabis use exacerbates psychosis symptoms, its neurocognitive effects remain unclear. Co-use of cannabis and tobacco is increasing in the general population, but little is known about its effects in people with psychosis or those at risk for developing a psychotic disorder,...

Occasional cannabis use is associated with higher premorbid functioning and IQ in youth at clinical high-risk (CHR) for psychosis: Parallel findings to psychosis cohorts

Schizophrenia Research July 30, 2024 L. Kennedy, B. Ku, Jean Addington et al.

Background: Neurocognitive deficits have been widely reported in clinical high-risk for psychosis (CHR) populations. Additionally, rates of cannabis use are high among CHR youth and are associated with greater symptom severity. Cannabis use has been sometimes shown to be associated with better neurocognition in more progressed psychosis cohorts, therefore in this study we aimed to determine...

Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis.

Schizophrenia Research August 25, 2022 Olga Santesteban-Echarri, Lu Liu, Madeline Miller et al.

Cannabis use is more prevalent among youth at clinical high-risk (CHR) for psychosis than healthy controls (HC). There is mixed evidence as to whether cannabis use is associated with increased severity of attenuated psychotic symptoms (APS) or whether current cannabis use is associated with the transition to psychosis. This study aims to assess cannabis use differences between CHR youth and HC...

Clinical phenomenology of the prodrome for psychosis

Oxford University Press eBooks November 1, 2020 Albert R. Powers, Thomas H. McGlashan, S. Woods 5 citations

More than 100 years of retrospective studies show that psychosis is usually preceded by a prodrome. Nonspecific symptoms such as anxiety and depression precede more specific negative and attenuated positive symptoms. Prospective diagnostic criteria have been developed based on the retrospective work. The prospective criteria have shown high reliability in the research context, and follow-up...

Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis

Psychiatry Research November 25, 2015 L. Buchy, L. Seidman, Kristin Cadenhead et al.

Among people with psychosis, those with a history of cannabis use show better cognitive performance than those who are cannabis naïve. It is unknown whether this pattern is present in youth at clinical high risk (CHR) of psychosis. We evaluated relationships between IQ and cannabis use while controlling for use of other substances known to impact cognition in 678 CHR and 263 healthy control...